🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2b, double blinded, randomized study of SYN023 compared to ...
Status
Completed
Location
University of Florida
Start Date
2019-09-03
Trial ID
NCT03961555
Treatments Being Tested
A prospective, randomized, blinded, parallel-group, non-inferiority, phase ...
Status
Completed
Location
Prism Research
Start Date
2017-12-08
Trial ID
NCT03264157
The goal of this clinical trial is to compare the efficacy and safety of GR...
Status
Completed
Location
Center for Disease Control and Prevention (CDC)
Start Date
2022-10-21
Trial ID
NCT05846568
Treatments Being Tested
The purpose of this study is to: 1. Evaluate the safety and tolerability of...
Status
Completed
Location
Prism Research Inc
Start Date
2013-04
Trial ID
NCT02040090
Treatments Being Tested
Primary Objective: To describe the immune response induced by VRVg-2 and V...
Status
Completed
Location
Investigational Site Number :7640004
Start Date
2020-08-04
Trial ID
NCT04478084
This multicenter, observer-blind, controlled, randomized, Phase II study wa...
Status
Completed
Location
Investigational Site
Start Date
2017-04-17
Trial ID
NCT03145766
Treatments Being Tested
A Phase II, Single-Center, Randomized, Blinded, Controlled Clinical Trial t...
Status
Not Yet Recruiting
Location
Lanzhou Institute of Biological Products Co., Ltd.
Start Date
2026-01-31
Trial ID
NCT07445815
Dosage of rabies immune globulin was calculated from the victim's body weig...
Status
Completed
Location
Queen Saovabha Memorial Institute, Thai Red Cross Society
Start Date
2012-06
Trial ID
NCT01610362
Treatments Being Tested
Study design: Single-blind (subject and observer-blinded), active-controll...
Status
Completed
Location
Lotus House, Vasanth Nagar
Start Date
2011-12
Trial ID
NCT01228383
This study evaluates the rabies virus neutralizing antibody (RVNA) activiti...
Status
Completed
Location
Multiple Locations
Start Date
2014-12
Trial ID
NCT02559921